GSK-PAR 29060 651 (BRL – 02960)

Study Sponsor: GSK

Study Title

A 12 week, double-blind, fixed dose comparison of 20 and 40 mg daily of paroxetine and placebo in Patients suffering from Post-traumatic Stress Disorder (PTSD).

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

PAR 29060 651 (BRL – 02960)

Trial Registry Identification Number(#'s)

Medical Condition

Post-Traumatic Stress Disorder

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=29060/651

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study. An annotated case report form, a reporting and analysis plan, a clinical study report, and a protocol are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

December 2014